Enrique Grande is Director of the Medical Oncology Program and Clinical Research Lead at the MD Anderson Cancer Center Madrid, Spain, where he guides specialist research programmes and palliative care services for patients with genitourinary and endocrine tumours. He is also a member of the board of directors and a founding partner of the Spanish Task Force Group for Orphan and Rare Tumours (Grupo Español de Tumores Huérfanos e Infrecuentes [GETHI]) and the Spanish Neuroendocrine Tumour Group (Grupo Español de Tumores Neuroendocrinos y Endocrinos [GETNE]), and a member of the Spanish Oncology Genitourinary Group (Grupo Español de Oncología Genitourinaria [SOGUG]), and also advisory board member of the European Neuroendocrine Tumor Society (ENETS).
Dr Grande’s primary research focus is in the area of genitourinary tumors; to date, he has participated in more than one hundred international clinical trials and has been instrumental in the approval of most of the current range of novel treatments for genitourinary and endocrine tumours. He has published more than 200 peer-reviewed publications across more than 150 scientific journals and numerous books or book chapters, and is associate editor of Kidney Cancer Journal, Clinical and Translational Oncology, Future Oncology, and World Journal of Clinical Oncology.
Previous to his current role, he was responsible for founding the Phase I Studies Unit of Oncological Drugs at the Ramon y Cajal Hospital, also in Madrid, where he initiated and oversaw the development of joint urology and oncology consultations, the multidisciplinary GU team, and which led to the unit designation as a national reference in the treatment of renal and germ-cell tumours.